Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Global Industrial
GIC
$1.48B
| $9.1M | 0.01% |
442,967
+89,900
| +25% | +$1.74M |
|
1277
German American Bancorp
GABC
$1.93B
| $9.09M | 0.01% |
292,400
-33,300
| -10% | -$959K |
|
1278
CEVA Inc
CEVA
$898M
| $9.09M | 0.01% |
242,900
-73,300
| -23% | -$2.35M |
|
1279
RLI Corp
RLI
$5.85B
| $9.08M | 0.01% |
221,200
+4,200
| +2% | +$166K |
|
1280
Tilly's
TLYS
$121M
| $9.06M | 0.01% |
1,597,710
-284,822
| -15% | -$1.47M |
|
1281
China Yuchai International
CYD
$1.69B
| $8.99M | 0.01% |
625,107
+88,824
| +17% | +$1.11M |
|
1282
Peoples Bancorp
PEBO
$1.49B
| $8.98M | 0.01% |
421,979
-88,300
| -17% | -$1.93M |
|
1283
Blue Bird Corp
BLBD
$2.06B
| $8.98M | 0.01% |
598,818
-51,600
| -8% | -$647K |
|
1284
Grupo Aval
AVAL
$6.34B
| $8.96M | 0.01% |
2,054,472
+170,350
| +9% | +$749K |
|
1285
Hewlett Packard
HPE
$78B
| $8.95M | 0.01% |
+920,000
| New | +$9.03M |
|
|
VLRS
1286
Controladora Vuela Compania de Aviacion
VLRS
$920M
| $8.95M | 0.01% |
1,694,900
-567,600
| -25% | -$2.68M |
|
1287
WaFd
WAFD
$2.81B
| $8.95M | 0.01% |
333,276
-8,800
| -3% | -$227K |
|
|
ACC
1288
DELISTED
American Campus Communities, Inc.
ACC
| $8.94M | 0.01% |
255,628
-244,584
| -49% | -$8.11M |
|
|
JBGS
1289
JBG SMITH
JBGS
$698M
| $8.92M | 0.01% |
301,800
+114,400
| +61% | +$3.54M |
|
|
BRG
1290
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $8.9M | 0.01% |
1,101,575
-362,188
| -25% | -$2.41M |
|
1291
Allient
ALNT
$1.88B
| $8.88M | 0.01% |
377,523
-61,950
| -14% | -$1.29M |
|
1292
Nomura Holdings
NMR
$28.7B
| $8.88M | 0.01% |
2,000,490
-47,700
| -2% | -$198K |
|
1293
Clarivate
CLVT
$1.23B
| $8.87M | 0.01% |
+397,400
| New | +$8.98M |
|
1294
Kamada
KMDA
$434M
| $8.85M | 0.01% |
1,139,945
+159,678
| +16% | +$1.2M |
|
1295
Helen of Troy
HELE
$706M
| $8.85M | 0.01% |
46,910
-20,900
| -31% | -$3.42M |
|
1296
Donegal Group Class A
DGICA
$694M
| $8.84M | 0.01% |
621,811
+28,200
| +5% | +$402K |
|
|
ILPT
1297
Industrial Logistics Properties Trust
ILPT
$603M
| $8.83M | 0.01% |
429,880
-160,800
| -27% | -$2.95M |
|
1298
Healthpeak Properties
DOC
$14.3B
| $8.82M | 0.01% |
320,109
+50,307
| +19% | +$1.28M |
|
1299
Orion Energy Systems
OESX
$78.1M
| $8.82M | 0.01% |
254,879
+18,800
| +8% | +$769K |
|
|
GAU
1300
Galiano Gold
GAU
$557M
| $8.82M | 0.01% |
6,630,479
+1,408,263
| +27% | +$1.58M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.